Bruker Total Assets from 2010 to 2024

BRKR Stock

USD 57.07 0.85 1.51%

Bruker Total Assets yearly trend continues to be relatively stable with very little volatility. Total Assets are likely to grow to about 4.5 B this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2000-03-31

Previous Quarter

5.9 B

Current Value

6.1 B

Quarterly Volatility

1.3 B

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Bruker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bruker's main balance sheet or income statement drivers, such as Interest Expense of 12.1 M, Total Revenue of 3.1 B or Gross Profit of 1.6 B, as well as many indicators such as Price To Sales Ratio of 5.18, Dividend Yield of 0.0026 or PTB Ratio of 14.38. Bruker financial statements analysis is a perfect complement when working with Bruker Valuation or Volatility modules.

Check out the analysis of Bruker Correlation against competitors.

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

Latest Bruker's Total Assets Growth Pattern

Below is the plot of the Total Assets of Bruker over the last few years. Total assets refers to the total amount of Bruker assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bruker books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Bruker's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bruker's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 4.25 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Bruker Total Assets Regression Statistics

	Arithmetic Mean	2,460,329,067
	Geometric Mean	1,939,674,411
	Coefficient Of Variation	47.33
	Mean Deviation	938,429,413
	Median	1,988,300,000
	Standard Deviation	1,164,364,190
	Sample Variance	1355744T
	Range	4.4B
	R-Value	0.92
	Mean Square Error	210918T
	R-Squared	0.86
	Slope	240,820,636
	Total Sum of Squares	18980415.5T

Bruker Total Assets History

	2024	4.5 B
	2023	4.2 B
	2022	3.6 B
	2021	3.6 B
	2020	3 B
	2019	2.8 B
	2018	2.1 B

Other Fundumenentals of Bruker

Intangibles To Total Assets

Bruker Total Assets component correlations

	Total Assets	Total Stockholder Equity	Total Liab	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Short Term Investments	Property Plant Equipment	Current Deferred Revenue	Treasury Stock	Good Will	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.99	0.85	0.97	0.53	0.95	0.76	0.26	0.22	0.55	0.95	-0.25	0.98	0.66	-0.89	0.95	0.72	0.94	0.8	0.14	0.17	0.88	0.69	-0.63
Total Stockholder Equity	0.97		0.94	0.78	0.93	0.5	0.95	0.73	0.23	0.33	0.67	0.86	-0.24	0.97	0.69	-0.79	0.91	0.72	0.83	0.73	0.15	0.15	0.76	0.53	-0.63
Total Liab	0.99	0.94		0.86	0.97	0.54	0.93	0.76	0.26	0.17	0.5	0.98	-0.24	0.97	0.63	-0.91	0.95	0.71	0.96	0.81	0.12	0.17	0.91	0.75	-0.62
Net Debt	0.85	0.78	0.86		0.91	0.51	0.87	0.39	0.3	-0.05	0.18	0.83	-0.24	0.87	0.65	-0.84	0.94	0.91	0.91	0.66	0.22	0.18	0.84	0.51	-0.83
Retained Earnings	0.97	0.93	0.97	0.91		0.46	0.94	0.65	0.3	0.2	0.43	0.94	-0.18	0.95	0.56	-0.95	0.99	0.79	0.95	0.85	0.2	0.22	0.89	0.64	-0.69
Accounts Payable	0.53	0.5	0.54	0.51	0.46		0.57	0.36	0.23	0.11	0.4	0.44	-0.38	0.56	0.73	-0.4	0.48	0.39	0.43	0.26	0.17	0.02	0.44	0.29	-0.39
Net Receivables	0.95	0.95	0.93	0.87	0.94	0.57		0.66	0.29	0.26	0.56	0.88	-0.28	0.97	0.71	-0.84	0.94	0.83	0.87	0.73	0.28	0.2	0.8	0.52	-0.66
Total Current Assets	0.76	0.73	0.76	0.39	0.65	0.36	0.66		0.14	0.38	0.76	0.76	-0.04	0.7	0.34	-0.67	0.59	0.25	0.64	0.79	0.02	0.14	0.71	0.65	0.0
Short Term Debt	0.26	0.23	0.26	0.3	0.3	0.23	0.29	0.14		-0.01	0.16	0.23	0.03	0.26	0.12	-0.32	0.25	0.17	0.25	0.27	0.34	0.97	0.18	0.12	-0.28
Intangible Assets	0.22	0.33	0.17	-0.05	0.2	0.11	0.26	0.38	-0.01		0.59	0.1	-0.27	0.15	-0.03	-0.16	0.19	-0.06	0.02	0.36	0.27	0.04	0.02	-0.09	0.13
Common Stock	0.55	0.67	0.5	0.18	0.43	0.4	0.56	0.76	0.16	0.59		0.38	-0.03	0.56	0.48	-0.29	0.36	0.19	0.26	0.44	0.01	0.15	0.26	0.12	-0.02
Long Term Debt	0.95	0.86	0.98	0.83	0.94	0.44	0.88	0.76	0.23	0.1	0.38		-0.17	0.91	0.49	-0.94	0.91	0.67	0.98	0.84	0.1	0.16	0.95	0.84	-0.53
Short Term Investments	-0.25	-0.24	-0.24	-0.24	-0.18	-0.38	-0.28	-0.04	0.03	-0.27	-0.03	-0.17		-0.28	-0.41	0.16	-0.3	-0.2	-0.21	-0.06	-0.47	0.12	-0.2	-0.03	0.3
Property Plant Equipment	0.98	0.97	0.97	0.87	0.95	0.56	0.97	0.7	0.26	0.15	0.56	0.91	-0.28		0.74	-0.85	0.94	0.8	0.9	0.73	0.16	0.16	0.83	0.59	-0.68
Current Deferred Revenue	0.66	0.69	0.63	0.65	0.56	0.73	0.71	0.34	0.12	-0.03	0.48	0.49	-0.41	0.74		-0.34	0.59	0.67	0.52	0.17	0.04	-0.05	0.46	0.2	-0.69
Treasury Stock	-0.89	-0.79	-0.91	-0.84	-0.95	-0.4	-0.84	-0.67	-0.32	-0.16	-0.29	-0.94	0.16	-0.85	-0.34		-0.93	-0.68	-0.94	-0.92	-0.25	-0.26	-0.92	-0.73	0.51
Good Will	0.95	0.91	0.95	0.94	0.99	0.48	0.94	0.59	0.25	0.19	0.36	0.91	-0.3	0.94	0.59	-0.93		0.83	0.94	0.81	0.25	0.16	0.89	0.59	-0.73
Net Tangible Assets	0.72	0.72	0.71	0.91	0.79	0.39	0.83	0.25	0.17	-0.06	0.19	0.67	-0.2	0.8	0.67	-0.68	0.83		0.74	0.49	0.21	0.08	0.66	0.25	-0.8
Long Term Debt Total	0.94	0.83	0.96	0.91	0.95	0.43	0.87	0.64	0.25	0.02	0.26	0.98	-0.21	0.9	0.52	-0.94	0.94	0.74		0.81	0.13	0.16	0.96	0.79	-0.65
Capital Surpluse	0.8	0.73	0.81	0.66	0.85	0.26	0.73	0.79	0.27	0.36	0.44	0.84	-0.06	0.73	0.17	-0.92	0.81	0.49	0.81		0.23	0.28	0.86	0.62	-0.26
Deferred Long Term Liab	0.14	0.15	0.12	0.22	0.2	0.17	0.28	0.02	0.34	0.27	0.01	0.1	-0.47	0.16	0.04	-0.25	0.25	0.21	0.13	0.23		0.33	0.13	-0.16	-0.16
Short Long Term Debt	0.17	0.15	0.17	0.18	0.22	0.02	0.2	0.14	0.97	0.04	0.15	0.16	0.12	0.16	-0.05	-0.26	0.16	0.08	0.16	0.28	0.33		0.11	0.06	-0.14
Net Invested Capital	0.88	0.76	0.91	0.84	0.89	0.44	0.8	0.71	0.18	0.02	0.26	0.95	-0.2	0.83	0.46	-0.92	0.89	0.66	0.96	0.86	0.13	0.11		0.79	-0.49
Net Working Capital	0.69	0.53	0.75	0.51	0.64	0.29	0.52	0.65	0.12	-0.09	0.12	0.84	-0.03	0.59	0.2	-0.73	0.59	0.25	0.79	0.62	-0.16	0.06	0.79		-0.24
Capital Stock	-0.63	-0.63	-0.62	-0.83	-0.69	-0.39	-0.66	0.0	-0.28	0.13	-0.02	-0.53	0.3	-0.68	-0.69	0.51	-0.73	-0.8	-0.65	-0.26	-0.16	-0.14	-0.49	-0.24

Click cells to compare fundamentals

About Bruker Financial Statements

Bruker shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Bruker investors may analyze each financial statement separately, they are all interrelated. The changes in Bruker's assets and liabilities, for example, are also reflected in the revenues and expenses on on Bruker's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	4.2 B	4.5 B
Intangibles To Total Assets	0.21	0.23

Pair Trading with Bruker

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bruker Stock

0.86	A	Agilent Technologies Earnings Call This Week	Pair Corr
0.9	ME	23Andme Holding	Pair Corr

Moving against Bruker Stock

0.81	EXEL	Exelixis	Pair Corr
0.74	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.56	EWTX	Edgewise Therapeutics	Pair Corr
0.45	KTTAW	Pasithea Therapeutics	Pair Corr

The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.

The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Bruker Stock Analysis

When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC